|
Dr. Daniel Savard brings more than 20 years of clinical practice and clinical research in cardiology. Dr. Savard holds a doctorate degree in medicine from Faculty of Medicine of Montreal University (1971-1976) and a license of the Medical Council of Canada. He completed postdoctoral training in Internal Medicine and in Cardiology at Montreal University (1976-1980) and a fellowship in clinical and research echocardiography at Quebec Heart Institute of Laval University. He has been certified in Cardiology from the Corporation des M�decins du Qu�bec and from the Royal College of Physicians and Surgeons of Canada. Dr. Savard is Professor of Medicine at University of Montreal and practicing at Centre Hospitalier Universitaire de Montreal, Notre-Dame Hospital in Montreal. His research interests are coronary heart disease, congestive heart failure, arterial hypertension, hyperlipidemia, angiogenesis therapy in coronary heart disease, circadian cycle, and ambulatory blood pressure monitoring. Dr. Savard is highly involved in clinical research. He participated in over 40 clinical trials or which several were international multicenter studies. He has been Principal Investigator, in his institution, for 25 of these studies. He has been member for several large pharmaceuticals clinical advisory boards for companies such as Pfizer Inc., Hoechst Marion Roussel, Biovail Corp., Crystaal Corp., and Aventis Pharma Inc. He is currently consultant for Biovail Corp. and for Medisys. Dr. Savard is Medical Assistant-Director of the Quebec Blue Cross (Canassistance inc.), Insurance Company and is member of the Board of Governors of Canassistance. He is member of the Soci�t� des M�decins-Experts du Qu�bec, where he does expertise evaluation in Cardiology mainly for Insurance companies, as an expert in civil liability and recently for La R�gie des Rentes du Qu�bec. He is an active member of several associations such as: the Association des Cardiologues du Qu�bec and the Association des M�decins Sp�cialistes du Qu�bec. Dr. Savard has published more than 40 manuscripts from his research. | 